Page last updated: 2024-10-31

minoxidil and Ureteral Neoplasms

minoxidil has been researched along with Ureteral Neoplasms in 1 studies

Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.

Ureteral Neoplasms: Cancer or tumors of the URETER which may cause obstruction leading to hydroureter, HYDRONEPHROSIS, and PYELONEPHRITIS. HEMATURIA is a common symptom.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kinoshita-Ise, M1
Foster, FS1
Shear, NH1

Other Studies

1 other study available for minoxidil and Ureteral Neoplasms

ArticleYear
Immune checkpoint inhibitor-related alopecia: Insight into the pathophysiology utilizing non-invasive diagnostic techniques.
    The Journal of dermatology, 2019, Volume: 46, Issue:5

    Topics: Administration, Topical; Aged; Alopecia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized;

2019